Inhibition of the JAK2/STAT3 pathway and cell cycle re‐entry contribute to the protective effect of remote ischemic pre‐conditioning of rat hindlimbs on cerebral ischemia/reperfusion injury. (23rd November 2022)
- Record Type:
- Journal Article
- Title:
- Inhibition of the JAK2/STAT3 pathway and cell cycle re‐entry contribute to the protective effect of remote ischemic pre‐conditioning of rat hindlimbs on cerebral ischemia/reperfusion injury. (23rd November 2022)
- Main Title:
- Inhibition of the JAK2/STAT3 pathway and cell cycle re‐entry contribute to the protective effect of remote ischemic pre‐conditioning of rat hindlimbs on cerebral ischemia/reperfusion injury
- Authors:
- Zhao, Yongmei
Ding, Mao
Yan, Feng
Yin, Jie
Shi, Wenjuan
Yang, Nan
Zhao, Haiping
Fang, Yalan
Huang, Yuyou
Zheng, Yangmin
Yang, Xueqi
Li, Wei
Ji, Xunming
Luo, Yumin - Abstract:
- Abstract: Aims: Remote ischemic pre‐conditioning (RIPC) protects against ischemia/reperfusion (I/R) injury. However, the mechanisms underlying this protection remain unclear. In the present study, we investigated the role of Janus‐activated kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway and cell cycle arrest, and their relationship with neuronal apoptosis following RIPC. Methods: A rat cerebral I/R injury model was induced by middle cerebral artery occlusion (MCAO), and AG490 was used to investigate the mechanisms of RIPC. p‐JAK2‐, p‐STAT3‐, cyclin D1‐, and cyclin‐dependent kinase 6 (CDK6) expression was assessed by Western blotting and immunofluorescence staining. Results: RIPC reduced the infarct volume, improved neurological function, and increased neuronal survival. Furthermore, p‐JAK2 and p‐STAT3 were detected during the initial phase of reperfusion; the expression levels were significantly increased at 3 and 24 h after reperfusion and were suppressed by RIPC. Additionally, the MCAO‐induced upregulation of the cell cycle regulators cyclin D1 and CDK6 was ameliorated by RIPC. Meanwhile, cyclin D1 and CDK6 were colocalized with p‐STAT3 in the ischemic brain. Conclusion: RIPC ameliorates the induction of the JAK2/STAT3 pathway and cell cycle regulators cyclin D1 and CDK6 by MCAO, and this net inhibition of cell cycle re‐entry by RIPC is associated with downregulation of STAT3 phosphorylation. Abstract : Three days' RIPC mitigates I/RAbstract: Aims: Remote ischemic pre‐conditioning (RIPC) protects against ischemia/reperfusion (I/R) injury. However, the mechanisms underlying this protection remain unclear. In the present study, we investigated the role of Janus‐activated kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway and cell cycle arrest, and their relationship with neuronal apoptosis following RIPC. Methods: A rat cerebral I/R injury model was induced by middle cerebral artery occlusion (MCAO), and AG490 was used to investigate the mechanisms of RIPC. p‐JAK2‐, p‐STAT3‐, cyclin D1‐, and cyclin‐dependent kinase 6 (CDK6) expression was assessed by Western blotting and immunofluorescence staining. Results: RIPC reduced the infarct volume, improved neurological function, and increased neuronal survival. Furthermore, p‐JAK2 and p‐STAT3 were detected during the initial phase of reperfusion; the expression levels were significantly increased at 3 and 24 h after reperfusion and were suppressed by RIPC. Additionally, the MCAO‐induced upregulation of the cell cycle regulators cyclin D1 and CDK6 was ameliorated by RIPC. Meanwhile, cyclin D1 and CDK6 were colocalized with p‐STAT3 in the ischemic brain. Conclusion: RIPC ameliorates the induction of the JAK2/STAT3 pathway and cell cycle regulators cyclin D1 and CDK6 by MCAO, and this net inhibition of cell cycle re‐entry by RIPC is associated with downregulation of STAT3 phosphorylation. Abstract : Three days' RIPC mitigates I/R injury by decreasing the induction of JAK2/STAT3 pathway and cell cycle regulators cyclin D1 and CDK6 by MCAO, and this net inhibition of cell cycle re‐entry by RIPC is associated with downregulation of STAT3 phosphorylation. … (more)
- Is Part Of:
- CNS neuroscience & therapeutics. Volume 29:Number 3(2023)
- Journal:
- CNS neuroscience & therapeutics
- Issue:
- Volume 29:Number 3(2023)
- Issue Display:
- Volume 29, Issue 3 (2023)
- Year:
- 2023
- Volume:
- 29
- Issue:
- 3
- Issue Sort Value:
- 2023-0029-0003-0000
- Page Start:
- 866
- Page End:
- 877
- Publication Date:
- 2022-11-23
- Subjects:
- cerebral ischemia/reperfusion -- cyclin D1 -- cyclin‐dependent kinases 6 -- Janus‐activated kinase 2/signal transducer and activator of transcription 3 -- remote ischemic pre‐conditioning
Neuropharmacology -- Periodicals
Central nervous system -- Diseases -- Effect of drugs on -- Periodicals
612.8 - Journal URLs:
- http://www.blackwell-synergy.com/loi/cnsnt ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cns.14023 ↗
- Languages:
- English
- ISSNs:
- 1755-5930
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9830.140000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25700.xml